1. Home
  2. ATXS vs ZKH Comparison

ATXS vs ZKH Comparison

Compare ATXS & ZKH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATXS
  • ZKH
  • Stock Information
  • Founded
  • ATXS 2008
  • ZKH 1998
  • Country
  • ATXS United States
  • ZKH China
  • Employees
  • ATXS N/A
  • ZKH N/A
  • Industry
  • ATXS Biotechnology: Pharmaceutical Preparations
  • ZKH
  • Sector
  • ATXS Health Care
  • ZKH
  • Exchange
  • ATXS Nasdaq
  • ZKH Nasdaq
  • Market Cap
  • ATXS 401.2M
  • ZKH 472.2M
  • IPO Year
  • ATXS 2015
  • ZKH 2023
  • Fundamental
  • Price
  • ATXS $5.86
  • ZKH $3.12
  • Analyst Decision
  • ATXS Strong Buy
  • ZKH Buy
  • Analyst Count
  • ATXS 7
  • ZKH 1
  • Target Price
  • ATXS $32.43
  • ZKH $4.00
  • AVG Volume (30 Days)
  • ATXS 479.1K
  • ZKH 27.4K
  • Earning Date
  • ATXS 08-11-2025
  • ZKH 05-20-2025
  • Dividend Yield
  • ATXS N/A
  • ZKH N/A
  • EPS Growth
  • ATXS N/A
  • ZKH N/A
  • EPS
  • ATXS N/A
  • ZKH N/A
  • Revenue
  • ATXS N/A
  • ZKH $1,217,705,644.00
  • Revenue This Year
  • ATXS N/A
  • ZKH $11.72
  • Revenue Next Year
  • ATXS N/A
  • ZKH $10.57
  • P/E Ratio
  • ATXS N/A
  • ZKH N/A
  • Revenue Growth
  • ATXS N/A
  • ZKH 2.24
  • 52 Week Low
  • ATXS $3.56
  • ZKH $2.50
  • 52 Week High
  • ATXS $12.92
  • ZKH $4.31
  • Technical
  • Relative Strength Index (RSI)
  • ATXS 62.16
  • ZKH 55.28
  • Support Level
  • ATXS $5.43
  • ZKH $2.87
  • Resistance Level
  • ATXS $5.97
  • ZKH $3.22
  • Average True Range (ATR)
  • ATXS 0.44
  • ZKH 0.24
  • MACD
  • ATXS 0.06
  • ZKH 0.01
  • Stochastic Oscillator
  • ATXS 82.37
  • ZKH 83.05

About ATXS Astria Therapeutics Inc.

Astria Therapeutics Inc is a biopharmaceutical company engaged to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Its lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in preclinical development for the treatment of hereditary angioedema. Their second product candidate is STAR-0310, a monoclonal antibody OX40 antagonist that is in preclinical development for the treatment of atopic dermatitis, or AD, an immune disorder associated with loss of skin barrier function and itching.

About ZKH ZKH Group Limited each representing thirty-five (35)

ZKH Group Ltd engages in providing MRO procurement service platform in China. It provides one-stop MRO procurement and management services for its customers, and offers digital and fulfillment solutions for participants along the industry value chain. It offers a broad range of MRO product offerings covering all MRO product lines on its platform, including spare parts, chemicals, manufacturing parts, general consumables, and office supplies. All of the Group's revenues are derived from the PRC.

Share on Social Networks: